Association of polymorphisms in the β2 and β3 adrenoceptor gene with polycystic ovary syndrome

被引:0
作者
Kurabayashi, Takumi
Yahata, Tetsuro
Quan, Jinhua
Tanaka, Kenichi
机构
[1] Niigata City Gen Hosp, Dept Obstet & Gynecol, Niigata, Niigata 9508739, Japan
[2] Niigata Univ, Sch Med, Niigata, Japan
关键词
polycystic ovary syndrome; beta; 3; adrenoceptor; genetic polymorphisms; 2;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To investigate polymorphisms of the beta 2 and beta 3 adrenoceptor (BAR-2 and BAR-3, respectively) genes associated with insulin-resistant polycystic ovary syndrome (PCOS) pathogenesis. STUDY DESIGN: Fifty-nine infertile Japanese women with PCOS and 97 healthy Japanese controls were studied. Blood metabolites and genomic DNA polymorphisms of BAR-2 (Arg16Glu) and Gln27Glu and BAR-3 (Trp64Arg) were analyzed. RESULTS: The PCOS group had significantly higher weight, body mass index, lipidemia and insulin resistance as compared to the control group. Glu 27 allele frequency in BAR-2 was significantly higher in PCOS patients as compared to the controls (0.07 vs 0.02, chi(2) = 5.91 p = 0.02, OR 4.63, 95% CI 1.35-5.93), while Gly 16 allele frequency was only slightly higher in the PCOS group as compared to the controls (0.58 vs. 0.47, chi(2) = 3.06, p = 0.08, OR 1.51, 95% CI 0.95-2.40). The Arg 64 allele frequency of BAR-3 was not significantly different between the 2 groups. Women with the Gly/Gly genotype for codon 16 or with either the Gln/Gln or Glu/Glu genotype for the codon 27 polymorphism of BAR-2 had significantly higher insulin resistance than those with the Arg/Arg and Gln/Gln genotypes. CONCLUSION: The polymorphism in codon 27 (Gln/Gln) of BAR-2 is linked to the expression of PCOS in Japanese women.
引用
收藏
页码:389 / 393
页数:5
相关论文
共 30 条
  • [1] β1 to β3 switch in control of cyclic adenosine monophosphate during brown adipocyte development explains distinct β-adrenoceptor subtype mediation of proliferation and differentiation
    Bronnikov, G
    Bengtsson, T
    Kramarova, L
    Golozoubova, V
    Cannon, B
    Nedergaard, J
    [J]. ENDOCRINOLOGY, 1999, 140 (09) : 4185 - 4197
  • [2] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25
  • [3] The Gly16→Arg16 and Gln27→Glu27 polymorphisms of β2-adrenergic receptor are associated with metabolic syndrome in men
    Dallongeville, J
    Helbecque, N
    Cottel, D
    Amouyel, P
    Meirhaeghe, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) : 4862 - 4866
  • [4] Microsatellite polymorphism (tttta)n at-528 base pairs of gene CYP11α influences hyperandrogenemia in patients with polycystic ovary syndrome
    Diamanti-Kandarakis, E
    Bartzis, MI
    Bergiele, AT
    Tsianateli, TC
    Kouli, CR
    [J]. FERTILITY AND STERILITY, 2000, 73 (04) : 735 - 741
  • [5] HYPERANDROGENIC ANOVULATION (PCOS) - A UNIQUE DISORDER OF INSULIN ACTION ASSOCIATED WITH AN INCREASED RISK OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    DUNAIF, A
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 98 : S33 - S39
  • [6] Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome
    El Mkadem, SA
    Lautier, C
    Macari, F
    Molinari, N
    Lefèbvre, P
    Renard, E
    Gris, JC
    Cros, G
    Daurès, JP
    Bringer, J
    White, MF
    Grigorescu, F
    [J]. DIABETES, 2001, 50 (09) : 2164 - 2168
  • [7] MEDICAL PROGRESS - POLYCYSTIC-OVARY-SYNDROME
    FRANKS, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (13) : 853 - 861
  • [8] Obesity and the polycystic ovary syndrome
    Gambineri, A
    Pelusi, C
    Vicennati, V
    Pagotto, U
    Pasquali, R
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (07) : 883 - 896
  • [9] Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism
    Gharani, N
    Waterworth, DM
    Batty, S
    White, D
    GillingSmith, C
    Conway, GS
    McCarthy, M
    Franks, S
    Williamson, R
    [J]. HUMAN MOLECULAR GENETICS, 1997, 6 (03) : 397 - 402
  • [10] Implications of genetic variability of human beta(2)-adrenergic receptor structure
    Green, SA
    Turki, J
    Hall, IP
    Liggett, SB
    [J]. PULMONARY PHARMACOLOGY, 1995, 8 (01): : 1 - 10